ReviewFrontiers in immunology2020
Schistosomiasis Pulmonary Arterial Hypertension.
Abstract readReview
In one paragraph
Review in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Pulmonary Immune Cell Landscape Altered by Exposure to HIV,International journal of molecular sciences · 2026Article
- Schistosomiasis-Associated Pulmonary Arterial Hypertension in Brazil: A Call to Action for Enhanced Diagnostic Recognition-2025 Pulmonary Vascular Research Institute Infection in Pulmonary Vascular Disease Consortium Perspectives.Pulmonary circulation · 2026Review
- Broiler Ascites Syndrome as a Potential Spontaneous Animal Model for Human Pulmonary Arterial Hypertension: A Narrative Review.Life (Basel, Switzerland) · 2026Review
- Clinical and hemodynamic evaluation of schistosomiasis-associated pulmonary arterial hypertension from Egyptian pulmonary hypertension centers: epidemiology, risk factors, and survival determinants.Scientific reports · 2026Article
- The context-dependent role of group 2 innate lymphoid cells in lung diseases.Acta biochimica et biophysica Sinica · 2026Review
- Schistosomiasis in Yemen: Focal Persistence, Possible Resurgence, and Challenges to Elimination.Research and reports in tropical medicine · 2026Review
- A Tale of Two Organs: The Liver-Lung Axis in Pulmonary Disease.Comprehensive Physiology · 2025Article
- Role of conventional dendritic cells in schistosomiasis-induced pulmonary hypertension.Clinical science (London, England : 1979) · 2025Article
- A pain from the nose to the head: neurological commitment during long COVID.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025Review
- Pathways to Diagnose Infectious Pulmonary Vascular Disease in Rural Mozambique.Infectious disease reports · 2025Article
- Rare but serious: pulmonary vascular disease around the world.JHLT open · 2025Review
- Global Landscape of Infection-Induced Pulmonary Hypertension.Infectious disease reports · 2025Review
- Morbidity and Mortality Associated With Pulmonary Arterial Hypertension in a Schistosomiasis-Endemic Region of Brazil.Pulmonary circulation · 2025Article
- Clinical, Functional, and Hemodynamic Profile of Schistosomiasis-Associated Pulmonary Arterial Hypertension Patients in Brazil: Systematic Review and Meta-Analysis.Infectious disease reports · 2025Review
- Adrenergic signaling during parasitic infections.Frontiers in immunology · 2025Review
- Treatment algorithm for pulmonary arterial hypertension.The European respiratory journal · 2024Review
- Infection and pulmonary vascular diseases consortium: United against a global health challenge.Pulmonary circulation · 2024Article
- ExperimentalPulmonary circulation · 2024Article
- Interstitial macrophage phenotypes inFrontiers in immunology · 2024Article
- Gut-Lung Axis in Focus: Deciphering the Impact of Gut Microbiota on Pulmonary Arterial Hypertension.Journal of personalized medicine · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Jean Pierre SibomanaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Tikur Anbessa Specialized Hospital, College of Health Sciences, University of Addis Ababa, Addis Ababa, Ethiopia.
Aloma CampecheDivision of Gastroenterology, Department of Medicine, Santa Casa Hospital, Salvador, Bahia, Brazil.
Roberto J Carvalho-FilhoDivision of Gastroenterology, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Ricardo Amorim CorreaInternal Medicine/Pulmonary Division, Medical School, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Helena DuaniInternal Medicine/Infectious Diseases Division, Medical School, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Virginia Pacheco GuimaraesPulmonary Department, Hospital Júlia Kubistchek, Fundação Hospitalar of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Joan F HiltonDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, United States.
Biruk KassaDepartment of Medicine, University of California San Francisco, San Francisco, CA, United States.
Rahul KumarDepartment of Medicine, University of California San Francisco, San Francisco, CA, United States.
Michael H LeeDepartment of Medicine, University of California San Francisco, San Francisco, CA, United States.
Camila M C LoureiroPulmonary Medicine, Santa Casa Hospital, Salvador, Bahia, Brazil.
Sula MazimbaDivision of Cardiology, Department of Medicine, University of Virginia School of Medicine, Charlottesville, VA, United States.
Claudia MickaelDepartment of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, United States.
Rudolf K F OliveiraDivision of Respiratory Diseases, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Jaquelina S Ota-ArakakiDivision of Respiratory Diseases, Department of Medicine, Federal University of São Paulo, São Paulo, Brazil.
Camila Farnese RezendePulmonary Medicine, Hospital das Clinicas, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Luciana C S SilvaInternal Medicine Department, Medical School, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil.
Edford SinkalaHepatology Clinic, Department of Medicine, University of Zambia Teaching Hospital, Lusaka, Zambia.
Hanan Yusuf AhmedDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Tikur Anbessa Specialized Hospital, College of Health Sciences, University of Addis Ababa, Addis Ababa, Ethiopia.
Brian B GrahamDepartment of Medicine, University of California San Francisco, San Francisco, CA, United States.
Funding
VRAC and Rho in pulmonary EC proliferationP01HL014985 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STENMARK, KURT R. · 1985 to 2019
$35.1MRole of Complement-Driven Pulmonary Vascular Inflammation in PHP01HL152961 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI DELANEY, CASSIDY A · 2020 to 2024
$14.1MInvestigating paclitaxel treatment in a pre-clinical model of Schistosoma-pulmonary hypertensionR01HL135872 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI Brian Barkley Graham · 2017 to 2026
$5.1MNHLBI NIH HHS P01 HL014985NHLBI NIH HHS P01 HL152961NHLBI NIH HHS R01 HL135872
Abstract
Pulmonary arterial hypertension (PAH) is a disease of the lung blood vessels that results in right heart failure. PAH is thought to occur in about 5% to 10% of patients with hepatosplenic schistosomiasis, particularly due to
Indexed as
AnimalsHumansLungPulmonary Arterial HypertensionSchistosoma mansoniSchistosomiasis mansoniTransforming Growth Factor betaVascular RemodelingTransforming Growth Factor betahepatosplenicneglected tropical diseasepulmonary hypertensionschistosomiasisTGF-betatype 2 inflammation
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.